Results 41 to 50 of about 3,589 (66)

STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer. [PDF]

open access: yesSignal Transduct Target Ther
Chibaudel B   +19 more
europepmc   +1 more source

Quantitative Parameters Derived Using the Biexponential and Stretched Exponential Models for the Detection of Early Renal Impairment in Chronic Kidney Disease. [PDF]

open access: yesCurr Med Imaging
Dai Y   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy